Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03974737 · ClinicalTrials.gov registry record
CRI in POTS in Adolescents
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 77
- Enrollment target
NCT03974737: Completed study, sponsored by University of Colorado, Denver.
NCT03974737 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03974737 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
The investigators aim to study whether the Compensatory Reserve Index (CRI) (an FDA approved device that assesses intravascular volume) can be used to evaluate severity of Postural Orthostatic Tachycardia Syndrome (POTS) and whether the CRI value has a correlation with severity of psychosocial symptoms and functional impairment associated with POTS.
Primary Outcome
This is a value between 0 and 1. The CRI values will be noted from minute 1 to minute 20. This study has only one visit.
Interventions
- DEVICE CRI device (non-invasive vitals sign measurement)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2020-09-22 |
What the finished NCT03974737 record still lists
NCT03974737 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CRI device (non-invasive vitals sign measurement) is the first listed.
NCT03974737 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03974737 about?
NCT03974737 is a clinical study titled "CRI in POTS in Adolescents". The investigators aim to study whether the Compensatory Reserve Index (CRI) (an FDA approved device that assesses intravascular volume) can be used to evaluate severity of Postural Orthostatic Tachycardia Syndrome (POTS) and whether the CRI value has a correlation with severity of psychosocial sympt...
What is the current status of trial NCT03974737?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2019-06-01. Estimated completion is 2020-09-22.
What interventions are being tested in trial NCT03974737?
The interventions under investigation include: CRI device (non-invasive vitals sign measurement) (DEVICE).
Who is sponsoring clinical trial NCT03974737?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI